Abiopharma

🔍 Cunningham Jennifer A. (Executive)

Company: 3M CO (MMM)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 7,049 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,049.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of 3M common stock.
• F2: The restricted stock units vest in three equal annual installments beginning on the date six months from the grant date.